Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT-I and Armodafinil for Insomnia and Fatigue in Cancer Survivors
NCT01019187Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Jun 2009
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of armodafinil in Insomnia and fatigue, sponsored by Abramson Cancer Center. Started Jun 2009; status: completed.
02
Drugs
armodafinil
03
Conditions
Insomniafatigue
Beyond the preview
Go deeper on NCT01019187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019187.